PMC:7283670 / 35135-36884
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T67091","span":{"begin":148,"end":153},"obj":"Body_part"},{"id":"T45012","span":{"begin":158,"end":164},"obj":"Body_part"},{"id":"T67712","span":{"begin":417,"end":421},"obj":"Body_part"},{"id":"T88534","span":{"begin":749,"end":766},"obj":"Body_part"},{"id":"T76233","span":{"begin":1064,"end":1069},"obj":"Body_part"}],"attributes":[{"id":"A6875","pred":"fma_id","subj":"T67091","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A73139","pred":"fma_id","subj":"T45012","obj":"http://purl.org/sig/ont/fma/fma228738"},{"id":"A93849","pred":"fma_id","subj":"T67712","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A15558","pred":"fma_id","subj":"T88534","obj":"http://purl.org/sig/ont/fma/fma7337"},{"id":"A42228","pred":"fma_id","subj":"T76233","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T62","span":{"begin":148,"end":153},"obj":"Body_part"},{"id":"T63","span":{"begin":158,"end":164},"obj":"Body_part"},{"id":"T64","span":{"begin":417,"end":421},"obj":"Body_part"},{"id":"T65","span":{"begin":1064,"end":1069},"obj":"Body_part"}],"attributes":[{"id":"A62","pred":"uberon_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A63","pred":"uberon_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"},{"id":"A64","pred":"uberon_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A65","pred":"uberon_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T200","span":{"begin":191,"end":199},"obj":"Disease"},{"id":"T201","span":{"begin":200,"end":209},"obj":"Disease"},{"id":"T202","span":{"begin":1176,"end":1184},"obj":"Disease"},{"id":"T203","span":{"begin":1267,"end":1284},"obj":"Disease"},{"id":"T204","span":{"begin":1286,"end":1298},"obj":"Disease"},{"id":"T205","span":{"begin":1312,"end":1324},"obj":"Disease"},{"id":"T206","span":{"begin":1483,"end":1491},"obj":"Disease"},{"id":"T207","span":{"begin":1492,"end":1501},"obj":"Disease"}],"attributes":[{"id":"A200","pred":"mondo_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A201","pred":"mondo_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A202","pred":"mondo_id","subj":"T202","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A203","pred":"mondo_id","subj":"T203","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A204","pred":"mondo_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/MONDO_0018076"},{"id":"A205","pred":"mondo_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A206","pred":"mondo_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A207","pred":"mondo_id","subj":"T207","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T329","span":{"begin":74,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T330","span":{"begin":91,"end":93},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T331","span":{"begin":148,"end":153},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T332","span":{"begin":366,"end":368},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T333","span":{"begin":417,"end":421},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T334","span":{"begin":417,"end":421},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T335","span":{"begin":768,"end":771},"obj":"http://purl.obolibrary.org/obo/CLO_0001196"},{"id":"T336","span":{"begin":773,"end":775},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T337","span":{"begin":901,"end":903},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T338","span":{"begin":905,"end":907},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T339","span":{"begin":1064,"end":1069},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T340","span":{"begin":1064,"end":1069},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T341","span":{"begin":1126,"end":1128},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T342","span":{"begin":1168,"end":1172},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T343","span":{"begin":1186,"end":1190},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T344","span":{"begin":1204,"end":1208},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T345","span":{"begin":1398,"end":1402},"obj":"http://purl.obolibrary.org/obo/CLO_0001203"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T75","span":{"begin":438,"end":440},"obj":"Chemical"},{"id":"T76","span":{"begin":447,"end":452},"obj":"Chemical"},{"id":"T77","span":{"begin":515,"end":520},"obj":"Chemical"},{"id":"T78","span":{"begin":564,"end":569},"obj":"Chemical"},{"id":"T79","span":{"begin":596,"end":601},"obj":"Chemical"},{"id":"T80","span":{"begin":1093,"end":1096},"obj":"Chemical"}],"attributes":[{"id":"A75","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A76","pred":"chebi_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A77","pred":"chebi_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A79","pred":"chebi_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A80","pred":"chebi_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T298","span":{"begin":0,"end":260},"obj":"Sentence"},{"id":"T299","span":{"begin":261,"end":291},"obj":"Sentence"},{"id":"T300","span":{"begin":292,"end":320},"obj":"Sentence"},{"id":"T301","span":{"begin":321,"end":361},"obj":"Sentence"},{"id":"T302","span":{"begin":362,"end":431},"obj":"Sentence"},{"id":"T303","span":{"begin":432,"end":503},"obj":"Sentence"},{"id":"T304","span":{"begin":504,"end":627},"obj":"Sentence"},{"id":"T305","span":{"begin":628,"end":631},"obj":"Sentence"},{"id":"T306","span":{"begin":632,"end":636},"obj":"Sentence"},{"id":"T307","span":{"begin":637,"end":659},"obj":"Sentence"},{"id":"T308","span":{"begin":660,"end":717},"obj":"Sentence"},{"id":"T309","span":{"begin":718,"end":767},"obj":"Sentence"},{"id":"T310","span":{"begin":768,"end":785},"obj":"Sentence"},{"id":"T311","span":{"begin":786,"end":813},"obj":"Sentence"},{"id":"T312","span":{"begin":814,"end":845},"obj":"Sentence"},{"id":"T313","span":{"begin":846,"end":998},"obj":"Sentence"},{"id":"T314","span":{"begin":999,"end":1054},"obj":"Sentence"},{"id":"T315","span":{"begin":1055,"end":1063},"obj":"Sentence"},{"id":"T316","span":{"begin":1064,"end":1070},"obj":"Sentence"},{"id":"T317","span":{"begin":1071,"end":1078},"obj":"Sentence"},{"id":"T318","span":{"begin":1079,"end":1104},"obj":"Sentence"},{"id":"T319","span":{"begin":1105,"end":1125},"obj":"Sentence"},{"id":"T320","span":{"begin":1126,"end":1156},"obj":"Sentence"},{"id":"T321","span":{"begin":1157,"end":1167},"obj":"Sentence"},{"id":"T322","span":{"begin":1168,"end":1185},"obj":"Sentence"},{"id":"T323","span":{"begin":1186,"end":1203},"obj":"Sentence"},{"id":"T324","span":{"begin":1204,"end":1221},"obj":"Sentence"},{"id":"T325","span":{"begin":1222,"end":1251},"obj":"Sentence"},{"id":"T326","span":{"begin":1252,"end":1300},"obj":"Sentence"},{"id":"T327","span":{"begin":1301,"end":1308},"obj":"Sentence"},{"id":"T328","span":{"begin":1309,"end":1363},"obj":"Sentence"},{"id":"T329","span":{"begin":1364,"end":1466},"obj":"Sentence"},{"id":"T330","span":{"begin":1467,"end":1675},"obj":"Sentence"},{"id":"T331","span":{"begin":1676,"end":1749},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T97","span":{"begin":200,"end":209},"obj":"Phenotype"},{"id":"T98","span":{"begin":1098,"end":1103},"obj":"Phenotype"},{"id":"T99","span":{"begin":1115,"end":1124},"obj":"Phenotype"},{"id":"T100","span":{"begin":1157,"end":1166},"obj":"Phenotype"},{"id":"T101","span":{"begin":1176,"end":1184},"obj":"Phenotype"},{"id":"T102","span":{"begin":1194,"end":1202},"obj":"Phenotype"},{"id":"T103","span":{"begin":1212,"end":1220},"obj":"Phenotype"},{"id":"T104","span":{"begin":1312,"end":1324},"obj":"Phenotype"},{"id":"T105","span":{"begin":1492,"end":1501},"obj":"Phenotype"}],"attributes":[{"id":"A97","pred":"hp_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A98","pred":"hp_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A99","pred":"hp_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/HP_0031246"},{"id":"A100","pred":"hp_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/HP_0002321"},{"id":"A101","pred":"hp_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A102","pred":"hp_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/HP_0002013"},{"id":"A103","pred":"hp_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A104","pred":"hp_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A105","pred":"hp_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1080","span":{"begin":1085,"end":1088},"obj":"Gene"},{"id":"1105","span":{"begin":1093,"end":1096},"obj":"Gene"},{"id":"1117","span":{"begin":79,"end":82},"obj":"Species"},{"id":"1118","span":{"begin":96,"end":101},"obj":"Species"},{"id":"1119","span":{"begin":210,"end":218},"obj":"Species"},{"id":"1120","span":{"begin":468,"end":476},"obj":"Species"},{"id":"1121","span":{"begin":1447,"end":1455},"obj":"Species"},{"id":"1122","span":{"begin":1665,"end":1673},"obj":"Species"},{"id":"1251","span":{"begin":191,"end":209},"obj":"Disease"},{"id":"1252","span":{"begin":1098,"end":1103},"obj":"Disease"},{"id":"1253","span":{"begin":1115,"end":1124},"obj":"Disease"},{"id":"1254","span":{"begin":1157,"end":1166},"obj":"Disease"},{"id":"1255","span":{"begin":1176,"end":1184},"obj":"Disease"},{"id":"1256","span":{"begin":1194,"end":1202},"obj":"Disease"},{"id":"1257","span":{"begin":1212,"end":1220},"obj":"Disease"},{"id":"1258","span":{"begin":1259,"end":1284},"obj":"Disease"},{"id":"1259","span":{"begin":1286,"end":1298},"obj":"Disease"},{"id":"1260","span":{"begin":1312,"end":1324},"obj":"Disease"},{"id":"1261","span":{"begin":1325,"end":1362},"obj":"Disease"},{"id":"1262","span":{"begin":1483,"end":1501},"obj":"Disease"}],"attributes":[{"id":"A1080","pred":"tao:has_database_id","subj":"1080","obj":"Gene:1401"},{"id":"A1105","pred":"tao:has_database_id","subj":"1105","obj":"Gene:26503"},{"id":"A1117","pred":"tao:has_database_id","subj":"1117","obj":"Tax:9606"},{"id":"A1118","pred":"tao:has_database_id","subj":"1118","obj":"Tax:9606"},{"id":"A1119","pred":"tao:has_database_id","subj":"1119","obj":"Tax:9606"},{"id":"A1120","pred":"tao:has_database_id","subj":"1120","obj":"Tax:9606"},{"id":"A1121","pred":"tao:has_database_id","subj":"1121","obj":"Tax:9606"},{"id":"A1122","pred":"tao:has_database_id","subj":"1122","obj":"Tax:9606"},{"id":"A1251","pred":"tao:has_database_id","subj":"1251","obj":"MESH:C000657245"},{"id":"A1252","pred":"tao:has_database_id","subj":"1252","obj":"MESH:D005334"},{"id":"A1253","pred":"tao:has_database_id","subj":"1253","obj":"MESH:D003371"},{"id":"A1254","pred":"tao:has_database_id","subj":"1254","obj":"MESH:D004244"},{"id":"A1255","pred":"tao:has_database_id","subj":"1255","obj":"MESH:D003967"},{"id":"A1256","pred":"tao:has_database_id","subj":"1256","obj":"MESH:D014839"},{"id":"A1257","pred":"tao:has_database_id","subj":"1257","obj":"MESH:D006261"},{"id":"A1258","pred":"tao:has_database_id","subj":"1258","obj":"MESH:D008171"},{"id":"A1259","pred":"tao:has_database_id","subj":"1259","obj":"MESH:D014376"},{"id":"A1260","pred":"tao:has_database_id","subj":"1260","obj":"MESH:D006973"},{"id":"A1261","pred":"tao:has_database_id","subj":"1261","obj":"MESH:D002318"},{"id":"A1262","pred":"tao:has_database_id","subj":"1262","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Shi et al. (2020), China Retrospective/hospitals in Wuhan 81, 49–5, 42 (52%) men and 39 (48%) women Next‐generation sequencing or RT‐PCR, serial chest CT Throat swab specimens Confirmed COVID‐19 pneumonia patients/direct exposure to Huanan seafood market: 31 (38%), health‐care workers: 15 (19%), familial clusters: 7 (9%), any obvious history of exposure: 28 (35%) Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9).\nCT:\nALL:\nbilateral abnormality: 64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: 53 [65%], mainly involving the right lower lobes: 225 [27%] of 849.\nGroup 1 (n=15): unilateral: 9 [60%]/multifocal 8 [53%]/GGO: 14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: 12 [40%]; Group 4 (n=15): consolidation/mixed patterns: 8 [53%].\nBlood:\nGroup1: Lower CRP and AST Fever: 59 [73%], dry cough: 48 [59%] nonspecific symptoms:\ndizziness:\n2 [2%], diarrhea:\n3 [4%], vomiting:\n4 [5%], headache:\n5 [6%], generalised weakness:\n7 [9%]/chronic pulmonary disease (tuberculosis): 1, T2D: 1, hypertension/cardiovascular/erebrovascular disease: 1 Symptom onset and discharge of 23–2 days 3 (4%) By February 8, 2020, 62 (77%) patients discharged\nInterpretation: COVID‐19 pneumonia include CT abnormalities that rapidly progress from focal unilateral to diffuse bilateral GGO coexisted with consolidations within 1–3 weeks (even in asymptomatic patients).\nEarly diagnosis through combined CT with clinical and laboratory findings"}